Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior (Q40108313)

17 September 2017

title

Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior (English)

1 reference

17 September 2017

Natasa Hlavacova

1

1 reference

17 September 2017

Daniela Jezova

series ordinal

2

1 reference

17 September 2017

publication date

21 February 2008

1 reference

17 September 2017

published in

Hormones and Behaviour

1 reference

17 September 2017

volume

54

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

90-97

1 reference

Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

The new biology of aldosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Increased plasma aldosterone in patients with clinical depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Is aldosterone synthesized within the rat brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Insulin-induced hypoglycemia activates the release of adrenocorticotropin predominantly via central and propranolol insensitive mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Corticosteroids in relation to fear, anxiety and psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Regulation of collecting duct AQP3 expression: response to mineralocorticoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Effects of Qi-training on anxiety and plasma concentrations of cortisol, ACTH, and aldosterone: a randomized placebo-controlled pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Voluntary wheel running modulates glutamate receptor subunit gene expression and stress hormone release in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Effect of environmental enrichment on stress related systems in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Nontraditional aspects of aldosterone physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Anxiety, defence and the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Psychological aspects of primary aldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Ultrastructure of rat initial collecting tubule. Effect of adrenal corticosteroid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Independent effects of aldosterone and potassium on induction of potassium adaptation in rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Different effects of three aldosterone treatments on plasma aldosterone and salt intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Toward a broader understanding of aldosterone in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2008.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YHBEH.2008.02.004

1 reference

17 September 2017

1 reference